The genetic test does not predict whether you will experience pancreatitis with GLP-1 use or how you will respond to semaglutide or tirzepatide
But this isnt to say you need more AHK-Cu the older you get
Hair treatment , backed by science Initial phase (2-3 months) In the first few months, there might be no visible change, and some individuals may experience temporary increased shedding of fine hairs
DOSING USED IN PHASE 3 STUDIES In the most recent studies from the TRIUMPH programme (Phase 3) , retatrutide was administered as follows: Route: Subcutaneous Frequency: Once weekly Study duration: Approximately 68 weeks Phase 3 Schedule Recommended Dosage (Clinical Research Escalation Model) Retatrutide is administered once weekly using a gradual dose escalation to improve tolerability
doi: 10.1016/j.phymed.2022.154626 225
Safety, Eligibility, and When to Discuss This with Your Provider GLP-1 medications carry known side effects including nausea, vomiting, and gastrointestinal distress